InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
-0.25%
)
US TECH 100
19,256.00
(
-0.01%
)
Dow Jones
39,134.76
(
0.00%
)
Brent Oil
84.87
(
-0.16%
)
Bitcoin
63,732.13
(
-1.68%
)
Post# of 252279
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

poorgradstudent

Send PM Follow Ignore
Followers 73
Posts 3426
Boards Moderated 1
Alias Born 04/28/2004

poorgradstudent

Re: Whalatane post# 213724

Tuesday, 09/19/2017 5:18:25 PM

Tuesday, September 19, 2017 5:18:25 PM

Post# of 252279
MYOK:

I think their data to date looks reasonable. As I mentioned earlier, I like their approach of reducing force production.

The targeted hypertrophic cardiomyopathy angle did turn out to be bunk, since they don't seem to be focusing on a mutation-driven strategy. I actually think that's a good thing.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up